Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated MelanomaGeorgina V. Long, John M. Kirkwood, Axel Hauschild et al.|New England Journal of Medicine|2017Cited by 1.5k
Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialN. Cascinelli, Filiberto Belli, Alberto Morabito et al.|The Lancet|1998Cited by 648
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trialAlexander M.M. Eggermont, Ulrich Keilholz, Alan Spatz et al.|The Lancet|2008Cited by 642
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaReinhard Dummer, Dirk Schadendorf, Axel Hauschild et al.|New England Journal of Medicine|2020Cited by 406
Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III MelanomaAlexander M.M. Eggermont, Ulrich Keilholz, Alessandro Testori et al.|Journal of Clinical Oncology|2012Cited by 281